Target definitions for Hodgkin lymphoma: The involved node radiation field concept

Radiotherapy for Hodgkin Lymphoma

Volumn , Issue , 2011, Pages 91-122

  Girinsky, Theodore ^a   Ghalibafian, Mithra ^b   Specht, Lena ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Mahak Hospital   (Iran)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892246694     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-78944-4_9     Document Type: Chapter

References (29)

1. Aleman BM, vanden Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21:3431-3439
2. Berthelsen AK, Holm S, Loft A et al (2005) PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32:1167-1175
3. Bhatia S, Robison LL, Oberlin O et al (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751
4. Biti GP, Cimino G, Cartoni C et al (1992) Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study. J Clin Oncol 10:378-382
5. Bonadonna G, Bonfante V, Viviani S et al (2004) ABVD plus subtotal nodal versus involved-field radiotherapy in earlystage Hodgkin's disease: long-term results. J Clin Oncol 22:2835-2841
6. Castellino RA, Hoppe RT, Blank N et al (1984) Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease. AJR Am J Roentgenol 143:37-41
7. Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244-1253
8. Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579-586
9. Donaldson SS, Link MP, Weinstein HJ et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 25:332-337
10. Girinsky T, vander Maazen R, Specht L et al (2006) Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79:270-277
11. Girinsky T, Ghalibafian M, Bonniaud G et al (2007) Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85:178-186
12. Girinsky T, Specht L, Ghalibafian M et al (2008) The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 88:202-210
13. Guermazi A (2001) Is it wise to eliminate lymphography from the staging of Hodgkin's disease? Leuk Lymphoma 42:655-660
14. Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955
15. Hanna SL, Fletcher BD, Boulden TF et al (1993) MR imaging of infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin disease: comparison with lymphography and CT. J Magn Reson Imaging 3:461-470
16. Hutchings M, Loft A, Hansen M et al (2007) Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78:206-212
17. ICRU (1993) Prescribing, recording and reporting photon beam therapy. Report 50
18. ICRU (1999) Prescribing, recording and reporting photon beam therapy. Report 62
19. Kyzas PA, Evangelou E, Denaxa-Kyza D et al (2008) 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 100:712-720
20. Landman-Parker J, Pacquement H, Leblanc T et al (2000) Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 18:1500-1507
21. Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636
22. Longo DL, Glatstein E, Duffey PL et al (1991) Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. J Clin Oncol 9:906-917
23. Mauch P (1995) Second malignancies after curative radiation therapy for good prognosis cancers. Int J Radiat Oncol Biol Phys 33:959-960
24. Ng AK, Bernardo MP, Weller E et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20:2101-2108
25. Pavlovsky S, Maschio M, Santarelli MT et al (1988) Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. J Natl Cancer Inst 80:1466-1473
26. Shahidi M, Kamangari N, Ashley S et al (2006) Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease. Radiother Oncol 78:1-5
27. Specht L (2007) 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol 17:190-197
28. Valette F, Querellou S, Oudoux A et al (2007) Comparison of positron emission tomography and lymphangiography in the diagnosis of infradiaphragmatic Hodgkin's disease. Acta Radiol 48:59-63
29. van Leeuwen FE, Klokman WJ, Stovall M et al (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980